POZ Latino / Hispanic Hub
Subscribe to:
POZ magazine
E-newsletters
Visit:
African American
Women
POZ Personals
Sign In / Join
Username:
Password:
 

Back to home » News & Views » Treatment News


 

March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007


emailrssprint

August 21, 2009

Longtime HIV Doc Named New Tobacco Regulator at FDA

Lawrence “Bopper” Deyton, MD, MSPH, for many years one of the greatest advocates for research and care for veterans living with HIV and hepatitis C virus (HCV), has been named by President Obama to the newly created post of director of the Center for Tobacco Products at the Food and Drug Administration (FDA), according to reporting by The New York Times.

Deyton, who is currently the chief public health and environmental hazards officer at the Veterans Health Administration, has years of experience coordinating services and research on HIV, HCV and other public health issues among veterans. He is also an associate professor at George Washington University, in Washington, DC, and still practices medicine.

The newly created division at the FDA has the power to regulate the sale and advertising of tobacco products, ban ads and force advertisements in stores to become no more than black and white text. The legislation creating the division has been controversial and, not surprisingly, unpopular with the tobacco and advertising industries. The new director will be tasked with building the new division from scratch. A national group representing advertisers has threatened to sue to stop the legislation from going into the effect.

Matthew L. Myers, president of the Campaign for Tobacco-Free Kids, helped craft the legislation to create the new program. “[Deyton] is extraordinarily bright, very committed and highly motivated,” Myers told the Times. “The FDA’s first and most important challenge is to build the center, hire top quality people and set priorities. He’s demonstrated capability in doing those things.”

NEW! Scroll down to comment on this story.

emailrssprint

 

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Previous Comments:

         


[Go to top]

"The Beginning of the End of AIDS" event on World AIDS Day 2011 in Washington, DC, at George Washington University. For more about the event, click here.
What to do if you've just been diagnosed
Qué hacer si eres recién diagnosticado

How to find a support system
Cómo encontrar un sistema de apoyo

Things you should know before starting treatment
Cosas que deberías saber antes de comenzar un tratamiento

How to handle side effects and other concerns
Cómo tratar los efectos secundarios y otros problemas de salud

How to tell someone you have HIV/AIDS
Cómo revelar tu diagnóstico de VIH/SIDA
[an error occurred while processing this directive]
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.